research use only

Aminophylline PDE inhibitor

Cat.No.S1673

Aminophylline (Phyllocontin) is a competitive nonselective phosphodiesterase inhibitor with an IC50 of 0.12 mM and also a nonselective adenosine receptor antagonist.
Aminophylline PDE inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 420.43

Quality Control

Batch: S167301 Water]81 mg/mL]false]DMSO]53 mg/mL]false]Ethanol]1 mg/mL]false Purity: 99.94%
99.94

Chemical Information, Storage & Stability

Molecular Weight 420.43 Formula

C16H24N10O4

Storage (From the date of receipt)
CAS No. 317-34-0 Download SDF Storage of Stock Solutions

Synonyms Phyllocontin Smiles CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N

Solubility

In vitro
Batch:

Water : 81 mg/mL

DMSO : 53 mg/mL ( (126.06 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 1 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
adenosine receptor [1]
PDE [1]
0.12 mM

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06134037 Completed
Anesthesia Brain Monitoring
University of Padova
November 12 2023 --
NCT06098196 Completed
Propofol|Anesthesia Brain Monitoring
University of Padova
October 25 2023 --
NCT03152942 Unknown status
Premature Obstetric Labor
St Stephens Aids Trust|Action Medical Research
October 5 2017 Phase 1
NCT02270827 Terminated
Asthma
Royal Brompton & Harefield NHS Foundation Trust
June 2014 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.

Signaling Pathway Map